JPRN-UMIN000010710已完成2 期
Effective treatment of rebamipide on xerostomia in Sjogrens syndrome patients:a pilot study -a double-blind placebo-controlled trial- - Effective treatment of rebamipide on xerostomia
Tochigi medical center0 个研究点目标入组 60 人开始时间: 2013年5月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with a history of treatment or currently on treatment for facial or trigeminal neuropathy. Patients with a history of treatment or currently on treatment salivary gland disorders other than SS within 6 months before start of administration. Patients with diabetes. Patients with hypersensitivity to rebamipide. Patients now taking or who took within one month previously rebamipide. Patients taking other drug for the treatment of gastritis and gastric ulcer. Patients who have or might have upper digestive tract, hepatic or biliary disease. Patients with severe hepatic dysfunction or renal dysfunction. Women who are pregnant or who might be pregnant or lactating mothers.
研究者
相似试验
招募中
不适用
Treatment for dry mouth sensation in patients after radiotherapy of head and neckPathological conditions, signs and symptomsdysgafiataste disordersswallowing disorderschanges in salivary secretionC07.465.815.929C10.597.751.861C06.405.117.119K11.7xerostomiaRBR-4smhk6Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo - HCFMRP/USP
Unknown
不适用
Rebamipide AND Sjögren SyndromeImproving Symptoms of Dry Mouth in Sjőgren's SyndromeNCT01759108University of Alexandria55
已完成
不适用
A trial of rebamipide for the healing of artificial ulcers after endoscopic submucosal dissection.Gastric tumorJPRN-UMIN000011715Yamaguchi University Graduate School of Medicine60
尚未招募
不适用
The efficacy of pilocarpine for xerostomia induced by radiation therapy at different administration timing.xerostomiaJPRN-UMIN000010288Kawasaki Medical School20
尚未招募
不适用
Management of dry mouth following radiation therapy: investigation of a new saliva substitute product.Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonxerostomiaACTRN12613000827730Jules Kieser40